Are all distal protection devices created equal?

Free article

Comment

Nick E J West et al. J Am Coll Cardiol. 2010.

Free article

. 2010 Aug 24;56(9):745-6; author reply 746.

doi: 10.1016/j.jacc.2010.04.036.

No abstract available

Comment on

Off-label use of drug-eluting stents putting it in perspective.
Grines CL. Grines CL. J Am Coll Cardiol. 2008 Feb 12;51(6):615-7. doi: 10.1016/j.jacc.2007.10.028. J Am Coll Cardiol. 2008. PMID: 18261679 Review. No abstract available.
Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
Chhatriwalla AK, Bhatt DL. Chhatriwalla AK, et al. Circ Cardiovasc Interv. 2008 Dec;1(3):217-25. doi: 10.1161/CIRCINTERVENTIONS.108.811380. Circ Cardiovasc Interv. 2008. PMID: 20031681 No abstract available.
Interpreting the music of drug-eluting stents: halcyon song or albatross dirge?
Mark DB. Mark DB. J Am Coll Cardiol. 2008 May 13;51(19):1854-6. doi: 10.1016/j.jacc.2008.02.038. J Am Coll Cardiol. 2008. PMID: 18466799 No abstract available.
Drug-eluting stent thrombosis.
Steinberg DH, Satler LF. Steinberg DH, et al. Minerva Cardioangiol. 2008 Feb;56(1):127-37. Minerva Cardioangiol. 2008. PMID: 18432175 Review.
Percutaneous coronary intervention: historical perspectives, current status, and future directions.
Arjomand H, Turi ZG, McCormick D, Goldberg S. Arjomand H, et al. Am Heart J. 2003 Nov;146(5):787-96. doi: 10.1016/S0002-8703(03)00153-4. Am Heart J. 2003. PMID: 14597926 Review.